4 completed, 1 terminated. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Terminated 1 |
Follow betrixaban: new trials by email Literature Review of betrixaban trials Research Report on betrixaban
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Betrixaban in Pediatric Participants Betrixaban - VTE Prophylaxis | Phase 1 | Terminated | Alexion Pharmaceuticals, Inc. | 21 | 2018-07-13 | 2024-01-12 |
| The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist Betrixaban - Hepatic Impairment | Phase 1 | Completed | Portola Pharmaceuticals | 32 | 2017-11-16 | 2023-02-21 |
| A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations Betrixaban - Healthy | Phase 1 | Completed | Portola Pharmaceuticals | 52 | 2015-09-01 | 2023-08-08 |
| A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment Betrixaban - Renal Impairment | Phase 1 | Completed | Portola Pharmaceuticals | 32 | 2009-07-31 | 2023-08-22 |
| A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers Betrixaban - Healthy Subjects | Phase 1 | Completed | Portola Pharmaceuticals | 8 | 2007-09-01 | 2023-08-08 |
Portola Pharmaceuticals (4) · Alexion Pharmaceuticals, Inc. (1)
United States (2) · Germany (1) · Russia (1) · Ukraine (1) · United Kingdom (1)
2018 (1)